Cineplex (TSX:CGX) Isn’t the Next AMC! Buy This Stock Instead

Interested in meme stocks? After watching AMC skyrocket, Canadians have poured into Cineplex stock. Here’s why you should reconsider.

| More on:

Meme stocks are all the rage these days. Earlier this year, investors that rode the GameStop pump saw their financial fortunes turn from rags to riches. Now, retail investors are clamouring for the AMC pump in hopes of achieving the same success. AMC stock is up nearly 900% in the past six months. In fact, the stock has gained more than 339% in the past month!

This has prompted some investors to think they’ve missed the pump. As a result, many are now looking for the next AMC. An easy equivalent to AMC in Canada is Cineplex (TSX:CGX). As a result, investors have been pouring into the stock hoping for the same results. In this article, I’ll explain why it’s dangerous to play this game and which stock you should consider buying instead.

Why Cineplex isn’t the next AMC stock

Many point to Cineplex as an equivalent to AMC because they’re industry peers and both stocks saw their value plummet during the pandemic. However, there’s no guarantee that Cineplex will ever see a similar pump in its stock. The American stock market possesses a lot more volume, which is needed for a move of AMC’s magnitude. If Cineplex stock never sees the same pump, investors could lose a lot of money from the added selling pressure as the crowd gives up hope on waiting.

As a long-term hold, Cineplex stock is also a bad choice. Because of the pandemic, Cineplex has struggled greatly. Year over year, the company’s Q1 revenue has decreased by 85.4%. Its total theatre attendance has declined even more drastically, falling 96.1% year over year. These are not promising numbers as the country exits the pandemic. As of its latest earnings report, Cineplex had a net cash burn of $26.9 million per month. This is greater than the remaining cash on the company’s balance sheet, as of March 31.

Buy this stock instead

Nuvei (TSX:NVEI) is a much better stock to add to your portfolio. Although it has nothing to do with the cinema industry, the stock should be appealing to a wide range of individuals. Nuvei provides payment solutions to companies around the world. It differentiates itself from its competitors by offering mobile, app, in-store, and unattended payment solutions. Today, the company is present in more than 200 global markets and accepts 450 payment methods in 150 currencies.

The stock has been one of the best performers on the TSX this year, gaining nearly 16%. Currently, Nuvei has a market cap of about $12 billion. This makes it much smaller than its competitors, which include PayPal (US$305 billion), Fiserv (US$76 billion), and Adyen (€57 billion). If Nuvei is able to reach the size of its competitors, investors could see returns of five times to 25 times.

It is certainly a newer company with an uphill battle ahead, but with customers already signed up, it’s very possible that Nuvei will become just as big as the other companies mentioned.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jed Lloren owns shares of Adyen. David Gardner owns shares of GameStop. The Motley Fool owns shares of and recommends PayPal Holdings and recommends the following options: long January 2022 $75 calls on PayPal Holdings.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »